Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Familial Cancer
Published in: Familial Cancer 4/2006

01-11-2006

Family History, and Impact on Clinical Presentation and Prognosis, in a Population-based Breast Cancer Cohort from the Stockholm County

Authors: Sara Margolin, Hemming Johansson, Lars Erik Rutqvist, Annika Lindblom, Tommy Fornander

Published in: Familial Cancer | Issue 4/2006

Login to get access
Metadata
Title
Family History, and Impact on Clinical Presentation and Prognosis, in a Population-based Breast Cancer Cohort from the Stockholm County
Authors
Sara Margolin
Hemming Johansson
Lars Erik Rutqvist
Annika Lindblom
Tommy Fornander
Publication date
01-11-2006
Publisher
Kluwer Academic Publishers
Published in
Familial Cancer / Issue 4/2006
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-006-7851-3

Other articles of this Issue 4/2006

Familial Cancer 4/2006 Go to the issue

Original Paper

Awareness of gynecologic surveillance in women from hereditary non-polyposis colorectal cancer families

Original Paper

Survival from Colorectal Carcinoma in HNPCC Families as Compared to the General Population in Lithuania – Initial Results

Original Paper

What is the appropriate screening protocol in Lynch syndrome?

Original Paper

Congenital hypertrophy of the retinal pigment epithelium (CHRPE) in familial colorectal cancer

Original paper

Low Prevalence of BRCA1 Exon Rearrangements in Familial and Young Sporadic Breast Cancer Patients

Original Paper

Accuracy of BRCA1 and BRCA2 Founder Mutation Analysis in Formalin-Fixed and Paraffin-Embedded (FFPE) Tissue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits